DBV Technologies (DBVT) news
Recent news
DBV Technologies: Portzamparc cuts target price to EUR 4.41 from EUR 4.90; rating 'accumulate'
AInvest Wire · Jul 31, 2026DBV Technologies announces sale of approximately $50 million of ADSs through its at-the-market (ATM) program on Nasdaq
DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Capital Market: DBVT), a clinical-stage biopharmaceutical company, has announced the sale of approximately $50 million of American Depositary Shares (ADSs) through its at-the-market (ATM) program on Nasdaq. The ADSs were issued under the…
AInvest Wire · Jul 30, 2026DBV Technologies SA files for mixed shelf; size not disclosed - SEC filing
DBV Technologies SA has filed a registration statement with the U.S. Securities and Exchange Commission (SEC) for a mixed shelf offering, according to a recent SEC filing [1]. A mixed shelf offering allows a company to register multiple types of securities, including common stock, preferred shares,…
AInvest Wire · Jul 27, 2026DBV Technologies files ATM prospectus for up to $150M of sales
AInvest Wire · Jul 17, 2026DBV Technologies SA falls 4.4% after Q2 results
AInvest Wire · Jul 17, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.